CUV 3.57% $14.52 clinuvel pharmaceuticals limited

Agree. And hope the BB does re-commence post results. You could...

  1. 772 Posts.
    lightbulb Created with Sketch. 219
    Agree. And hope the BB does re-commence post results. You could argue the current SP is reasonable if you afford it a relative low PE - If they maintain around 60c per share earnings, at 20 PE would value them around $12. Unsure re earnings but given the adolescent label has been delayed and no other material income outside EPP, similar earnings to last year would not surprise. A slightly higher Div won’t hurt. Of course adding in the pipeline changes everything but fair the market wants to see the money first. For recent investor’s, the last 3 years results wouldn’t be encouraging IMO. Hopefully they get some momentum back in the next 2 years. Finger’s crossed results are better. GLTA
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.